Abstract:Aim The aim was to evaluate the impact of metabolic syndrome (MS), MS individual components and 32 kinds of MS specific component combinations on all-cause mortality risk in a fixed cohort of MJ check-up population. Methods We observed the events of death in a fixed cohort, where the population was composed of 45,542 individuals aged 35–74 who were examined at MJ Health check-up Center in 1997 as baseline examination, and were followed up to 2005. Median duration of follow-up was 7.44 years. MS was defined according to the National Cholesterol Educational Program (the revised NCEP-ATPIII for Asian in 2004), the prevalence of MS was standardized according to China’s fifth census data. We constructed common Cox regression model, simultaneously adjusting the classic risk factors (such as age, sex, smoking, alcohol drinking, physical activity, family history, etc.) to examine the relationship between MS, MS individual components and 32 kinds of MS specific component combinations on the occurrence of death with the fixed cohort. Results The standardized prevalence of MS was 29.75% (male: 30.36%, female: 29.51%). There were 1,749 persons who died during the median 7.44-years follow-up, the mortality rate was 46 per 10,000 person years. The mortality rates were 71 and 35 per 10,000 person years for those with and without MS, respectively. After adjustment for age, sex and classical risk factors, compared with subjects without MS, the hazard ratio of all-cause mortality was 1.26 (95% CI: 1.14–1.40). The all-cause mortality were more highly significant than other combinations (P <0.05) when the following combinations exist: “elevated blood pressure”, “elevated fasting plasma glucose + low high-density lipoprotein cholesterol”, “elevated blood pressure + elevated triglyceride + elevated fasting plasma glucose”, “elevated fasting plasma glucose + low high-density lipoprotein cholesterol + elevated blood pressure + elevated triglyceride”. After adjusting age, sex and classical risk factors, the HRs for those with 0 to 5 components were 1, 1.22, 1.25, 1.33, 1.66, and 1.92, respectively. There was a significant dose-response relationship (P for liner trend <0.001) between the number of MS components and the risk of all-cause mortality in the overall fixed cohort sample. Conclusion In a large scale middle-aged Taiwan check-up population, MS may be associated with a much higher risk for all-cause mortality. These results may underline the fact that MS is a non-homogeneous syndrome and have a significant impact on detecting high-risk individuals suffering from metabolic disorders for preventing and controlling death.

Association Between Metabolic Syndrome and Mortality: Prospective Cohort Study.

Metabolic syndrome and its individual components with mortality among patients with coronary heart disease

Association of metabolic syndrome and sarcopenia with all-cause and cardiovascular mortality: a prospective cohort study based on the NHANES

The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome

The Associations of Metabolic Syndrome with Incident Hypertension, Type 2 Diabetes Mellitus and Chronic Kidney Disease: a Cohort Study

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

GW26-e4605 The Cohort Study on Prediction of Incidence of all-caused Mortality by Metabolic Syndrome

Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study

Association of metabolic score for visceral fat with all‐cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study

Does Diagnosis of Metabolic Syndrome Further Predict Risk of All Cause Mortality Beyond Conventional Cardiovascular Risk Factors in Middle Aged Chinese Men

Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis

Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan

Association of Serum 25-Hydroxyvitamin D with the Incidence of 16 Cancers, Cancer Mortality, and All-Cause Mortality among Individuals with Metabolic Syndrome: a Prospective Cohort Study

Associations between body fat anthropometric indices and mortality among individuals with metabolic syndrome

Association Between Metabolic Syndrome and Prognosis of Breast Cancer: a Meta-Analysis of Follow-Up Studies

Occurrence of metabolic syndrome in midlife in relation to cardiovascular morbidity and all-cause mortality-lessons from a population-based matched cohort study with 27 years follow-up

Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population

A prospective study on association of metabolic syndrome with cardiovascular disease

Incidence and long-term specific mortality trends of metabolic syndrome in the United States

Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China

Association Between Metabolic Syndrome and Endometrial Cancer Risk: a Systematic Review and Meta-Analysis of Observational Studies